Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Clinical and Molecular Models of Prognostication in Mastocytosis: Analysis Based on 580 Consecutive Cases

Animesh Pardanani, MBBS, PhD, Yoseph Elala, MD, Sahrish Shah, MD, Terra L. Lasho, PhD, Mrinal M. Patnaik, MDMBBS, Darci Zblewski, APRN, C-NP, Rhett P. Ketterling, Curtis A. Hanson, MD, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 582.

https://doi.org/10.1182/blood-2018-99-113914

Published: 2018

Journal Articles

Cytogenetic Abnormalities in Systemic Mastocytosis: Who Subcategory-Specific Incidence and Prognostic Impact Among 348 Informative Cases

Sahrish Shah, MD, Animesh Pardanani, MBBS, PhD, Yoseph Elala, MD, Terra L. Lasho, PhD, Mrinal M. Patnaik, MD MBBS, Kaaren K. Reichard, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 3050.

https://doi.org/10.1182/blood-2018-99-112628

Published: 2018

Journal Articles

A 27-Gene NGS Panel in Primary Myelofibrosis Identifies ASXL1 , CBL , RUNX1 and SRSF2 Mutations As Being Unfavorable and Absence of Any Non-Driver Mutation As Being Favorable to Survival

Ayalew Tefferi, MD, Terra L. Lasho, PhD, Christy Finke, BS, Yoseph Elala, MD, Daniela Barraco, MD, Naseema Gangat, MBBS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD

Blood (2015) 126 (23): 350.

https://doi.org/10.1182/blood.V126.23.350.350

Published: 2015

Journal Articles

Targeted Next-Generation Sequencing in Polycythemia Vera and Essential Thrombocythemia

Ayalew Tefferi, MD, Terra L. Lasho, PhD, Christy Finke, BS, Yoseph Elala, MD, Daniela Barraco, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS

Blood (2015) 126 (23): 354.

https://doi.org/10.1182/blood.V126.23.354.354

Published: 2015

Journal Articles

Peripheral Blood JAK2V617F Quantitative Assessment in Clinical Practice: Correlations Between Allele Burden and Clinical Phenotype

Animesh Pardanani, MBBS, PhD, Yoseph Elala, MD, Rong He, MD, Curtis A. Hanson, MD, Ayalew Tefferi, MD

Blood (2015) 126 (23): 2819.

https://doi.org/10.1182/blood.V126.23.2819.2819

Published: 2015

Journal Articles

Driver Mutations and Prognosis in 502 Patients with Essential Thrombocythemia

Yoseph Elala, MD, Terra L. Lasho, PhD, Naseema Gangat, MBBS, Christy Finke, BS, A Kamel Abou Hussein, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2015) 126 (23): 1599.

https://doi.org/10.1182/blood.V126.23.1599.1599

Published: 2015

Journal Articles

Driver Mutations and Prognosis in 1118 Patients with Primary Myelofibrosis

Ayalew Tefferi, MD, Paola Guglielmelli, PhDMD, Terra L. Lasho, PhD, Yoseph Elala, MD, Tiziana Fanelli, MSc, Naseema Gangat, MBBS, Christy Finke, BS, Giada Rotunno, MSc, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Alessandro M. Vannucchi, MD

Blood (2015) 126 (23): 2801.

https://doi.org/10.1182/blood.V126.23.2801.2801

Published: 2015

Journal Articles

Survival Trends in Essential Thrombocythemia in the Face of Changing Treatment Practices

A Kamel Abou Hussein, MD, Naseema Gangat, MBBS, Yoseph Elala, MD, Alexandra Wolanskyj, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2015) 126 (23): 2805.

https://doi.org/10.1182/blood.V126.23.2805.2805

Published: 2015

Journal Articles

Arterial Versus Venous Events in Essential Thrombocythemia and Their Impact on Overall and Thrombosis Free Survival

A Kamel Abou Hussein, MD, Naseema Gangat, MBBS, Yoseph Elala, MD, Curtis A. Hanson, MD, Animesh Pardanani, MBBS, PhD, Tiziano Barbui, MD, Ayalew Tefferi, MD

Blood (2015) 126 (23): 1611.

https://doi.org/10.1182/blood.V126.23.1611.1611

Published: 2015

NARROW

Clinical and Molecular Models of Prognostication in Mastocytosis: Analysis Based on 580 Consecutive Cases

Cytogenetic Abnormalities in Systemic Mastocytosis: Who Subcategory-Specific Incidence and Prognostic Impact Among 348 Informative Cases

A 27-Gene NGS Panel in Primary Myelofibrosis Identifies ASXL1 , CBL , RUNX1 and SRSF2 Mutations As Being Unfavorable and Absence of Any Non-Driver Mutation As Being Favorable to Survival

Targeted Next-Generation Sequencing in Polycythemia Vera and Essential Thrombocythemia

Peripheral Blood JAK2V617F Quantitative Assessment in Clinical Practice: Correlations Between Allele Burden and Clinical Phenotype

Driver Mutations and Prognosis in 502 Patients with Essential Thrombocythemia

Driver Mutations and Prognosis in 1118 Patients with Primary Myelofibrosis

Survival Trends in Essential Thrombocythemia in the Face of Changing Treatment Practices

Arterial Versus Venous Events in Essential Thrombocythemia and Their Impact on Overall and Thrombosis Free Survival

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only